The Effects of Aerosolized STAT1 Antisense Oligodeoxynucleotides on Rat Pulmonary Fibrosis

Previous study showed that aerosolized signal transducer and activator of transcription-1 (STAT1) antisense oligodeoxynucleotide (ASON) inhibited the expression of STAT1 and ICAM-1 mRNA and protein in alveolar macrophages (AMs) and decreased the concentrations of TGF-β, PDGF and TNF-α in bronchioalv...

Full description

Saved in:
Bibliographic Details
Published inCellular & molecular immunology Vol. 6; no. 1; pp. 51 - 59
Main Authors Wang, Wen Jun, Liao, Bin, Zeng, Ming, Zhu, Chen, Fan, Xian Ming
Format Journal Article
LanguageEnglish
Published China Nature Publishing Group 01.02.2009
The Department of Respiratory Medicine, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China%The Department of Cardiothoracic Surgery, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previous study showed that aerosolized signal transducer and activator of transcription-1 (STAT1) antisense oligodeoxynucleotide (ASON) inhibited the expression of STAT1 and ICAM-1 mRNA and protein in alveolar macrophages (AMs) and decreased the concentrations of TGF-β, PDGF and TNF-α in bronchioalveolar lavage fluid (BALF) in bleomycin (BLM)-induced rat pulmonary fibrosis. Administration of STAT1 ASON ameliorated alveolitis in rat pulmonary fibrosis. However, further investigations are needed to determine whether there is an effect from administration of STAT1 ASON on fibrosis. This study investigated the effect of aerosolized STAT1 ASON on the expressions of inflammatory mediators, hydroxyproline and type Ⅰ and type Ⅲcollagen mRNA in BLM-induced rat pulmonary fibrosis. The results showed that STAT1 ASON applied by aerosolization could ameliorate alveolitis and fibrosis, inhibit the expressions of inflammatory mediators, decrease the content of hydroxyproline, and suppress the expressions of type Ⅰand type Ⅲcollagen mRNA in lung tissue in BLM-induced rat pulmonary fibrosis. These results suggest that aerosolized STAT1 ASON might be considered as a promising new strategy in the treatment of pulmonary fibrosis. Cellular & Molecular Immunology.
Bibliography:11-4987/R
pulmonary fibrosis, STAT1, ASON, inflammatory mediator, type Ⅰ and type Ⅲcollagen mRNA
R563
R735.2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-7681
2042-0226
DOI:10.1038/cmi.2009.7